French CDMO key player in drug development and delivery of oral technologies serving the pharma and bio industries.
Skyepharma is an expert CDMO specialized in formulating, developing, and producing complex oral dosage forms with tailor-made modified-release profiles.
We offer a full range of services, from early-stage development to industrial manufacturing and packaging.
Our scientific expert team, supported by our patented technologies, has a solid track record of successful development, reformulation, and technology transfer projects.
Our GMP site, located in France and approved by the FDA, ANVISA, and the Korean MFDS, serves customers worldwide with a recognized high level of service.
Know More: https://www.skyepharma.com/